Medtronic (MDT) Short-term Investments (2014 - 2026)

Medtronic has disclosed Short-term Investments across 13 years of filings, most recently posting $7.2 billion for Q1 2026.

• Short-term Investments for Q1 2026 came in at $7.2 billion, up 8.29% year-over-year; the trailing twelve-month figure through Jan 2026 was $7.2 billion (up 8.29% YoY), and the FY2025 annual result was $6.7 billion, changed 0.39% from the prior year.
• Short-term Investments came in at $7.2 billion for Q1 2026 at Medtronic, up from $7.0 billion in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $7.7 billion in Q1 2022 to a low of $6.4 billion in Q2 2023.
• The 5-year median for Short-term Investments is $6.7 billion (2024), against an average of $6.8 billion.
• Across the five-year window, Short-term Investments fell 19.03% in 2022 and grew 8.29% in 2026, its largest moves.
• Medtronic's Short-term Investments stood at $6.6 billion in 2022, then fell by 2.71% to $6.4 billion in 2023, then gained by 2.68% to $6.6 billion in 2024, then increased by 6.82% to $7.0 billion in 2025, then increased by 2.71% to $7.2 billion in 2026.
• The last three Short-term Investments figures came in at $7.2 billion (Q1 2026), $7.0 billion (Q4 2025), and $6.8 billion (Q3 2025), per Business Quant data.